Bisulfate-based amplicon sequencing (BSAS) technique revealed that methylation of the PAX8 promoter region in the two endometrial cancer cells was significantly lower than that in the control cells (Fig. 2A–C, Supplementary Fig. 2). Here, PAX8 is linked to endometrial cancer.